ReviewCurrent allergy and asthma reports2026

Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence.

Pier-Valerio Mari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.